Pharmacoeconomic considerations in the treatment of breast cancer
Athanasios Pallis1, Vasiliki Tsiantou2, Efi Simou3, Nikos Maniadakis41Department of Medical Oncology, University General Hospital of Heraklion, Crete; 2Department of Health Economics, 3Department of Epidemiology and Biostatistics; 4Department of Health Services Organization and Management, National...
Saved in:
Main Authors: | Athanasios Pallis (Author), Vasiliki Tsiantou (Author), Efi Simou (Author), et al (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy
by: Sudhir C. Sarangi, et al.
Published: (2020) -
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
by: Kem P Krueger, et al.
Published: (2009) -
PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015) -
Pharmacoeconomic particulars of ovaries cancer's treatment
by: V N Zhurman, et al.
Published: (2015) -
Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018)